Biblio

Author Title [ Type

] Year

Filters: Author is Kopińska, Anna [Clear All Filters]

Journal Article

Kopińska A, Krawczyk-Kuliś M, Wieczorkiewicz-Kabut A, Koclęga A, Jagoda K, Dziaczkowska-Suszek J, Helbig G. Effect of transplanted cells with CD184, CD26 expressions and reconstitution of CD3+ lymphocyte population on long-term survival after autologous hematopoietic stem cell transplantation for multiple myeloma. Exp Hematol. 2023.

Drozd-Sokołowska J, Zaucha JMaciej, Żółtak T, Jamroziak K, Grzybowska-Izydorczyk O, Witkowska M, Waszczuk-Gajda A, Kaźmierczak M, Szczepaniak A, Subocz E, et al. Hodgkin lymphoma transformation of chronic lymphocytic leukemia - a real life data from the Polish Lymphoma Research Group. Hematol Oncol. 2019.

Avivi I, Vesole DH, Dávila-Valls J, Usnarska-Zubkiewicz L, Olszewska-Szopa M, Milunovic V, Baumert B, Osękowska B, Kopińska A, Gentile M, et al. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients. Cancers (Basel). 2023;15(17).

Kopińska A, Helbig G, Frankiewicz A, Grygoruk-Wiśniowska I, Kyrcz-Krzemień S. Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation. Contemp Oncol (Pozn). 2012;16(3):215-217.

Drozd-Sokołowska J, Waszczuk-Gajda A, Topczewska M, Manko J, Hus I, Szmigielska-Kapłon A, Nowicki M, Grygoruk-Wiśniowska I, Krawczyk-Kuliś M, Romejko-Jarosińska J, et al. Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group. J Clin Apher. 2021.